{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:31:09Z","timestamp":1771655469460,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Angiopoietins modulate endothelial permeability via endothelial cell junctions. Angiopoietin-2 blocks the angiopoietin-1\/Tie-2 interaction that stabilizes these junctions, and elevated plasma angiopoietin-2 levels are associated with vascular leakage. We hypothesized that plasma angiopoietin-1 and angiopoietin-2 levels are associated with indirect markers of increased vascular permeability, organ dysfunction, mortality, and plasma proinflammatory cytokine levels in human septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Multicenter observational cohort study derived from a randomized controlled trial (Vasopressin and Septic Shock Trial of vasopressin versus norepinephrine in septic shock).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>ICUs of hospitals in Canada, Australia, and the United States.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Three hundred forty-one patients in the randomized, controlled Vasopressin and Septic Shock Trial trial of vasopressin versus norepinephrine in septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurement and Main Results:<\/jats:title>\n            <jats:p>We measured plasma levels of angiopoietin-1 and angiopoietin-2 at study baseline and determined their association with percent fluid overload and acute organ dysfunction and generated a receiver operating characteristic curve for plasma angiopoietin-2 levels versus acute kidney injury. We also determined the association of angiopoietin-1 and angiopoietin-2 levels with hemodynamics, mortality, and plasma cytokine levels. Plasma angiopoietin-2 levels were directly associated with percent fluid overload at baseline (<jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.18; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0008) and at 6 hours (<jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.13; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.023), but not at 24 hours (<jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.041; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.46). Plasma angiopoietin-2 levels were associated with the development of hepatic (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001) and coagulation (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001) dysfunction and acute kidney injury (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001). Receiver operating characteristic curve had an area under the curve of 0.73 for acute kidney injury. angiopoietin-2 levels were also inversely associated with days alive (<jats:italic toggle=\"yes\">r<\/jats:italic> = \u20130.24; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.010) and positively associated with increased 7-day (log-rank trend chi-square = 5.9; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.015) and 28-day (log-rank chi square = 4.9; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.027) mortality. A threshold of angiopoietin-2 levels above the first quartile (&gt; 5,807 pg\/mL) was observed to be associated with increased mortality risk, which aligns with prior studies. Plasma angiopoietin-2 levels were positively associated with plasma cytokine levels, including tumor necrosis factor-\u03b1 and interleukin-6 at baseline (<jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.39; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001 and <jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.51; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001) and at 24 hours (<jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.29; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001 and <jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sub>s<\/jats:sub> = 0.41; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Increased plasma angiopoietin-2 levels are associated with increased fluid overload, hepatic and coagulation dysfunction, acute kidney injury, mortality, and plasma cytokines in human septic shock. angiopoietin-2 activation may increase vascular leakage leading to increased fluid requirements, organ dysfunction, and death from septic shock.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000001853","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T15:56:22Z","timestamp":1468943782000},"page":"2018-2027","source":"Crossref","is-referenced-by-count":66,"title":["Elevated Plasma Angiopoietin-2 Levels Are Associated With Fluid Overload, Organ Dysfunction, and Mortality in Human Septic Shock"],"prefix":"10.1097","volume":"44","author":[{"given":"Jane","family":"Fisher","sequence":"first","affiliation":[{"name":"Centre for Heart Lung Innovation, St. Paul\u2019s Hospital and University of British Columbia, Vancouver, BC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Centre for Heart Lung Innovation, St. Paul\u2019s Hospital and University of British Columbia, Vancouver, BC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Linder","sequence":"additional","affiliation":[{"name":"Centre for Heart Lung Innovation, St. Paul\u2019s Hospital and University of British Columbia, Vancouver, BC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.","volume":"10","author":"Augustin","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.RES.87.7.603","article-title":"Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions.","volume":"87","author":"Gamble","year":"2000","journal-title":"Circ Res"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat Med"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.105.086553","article-title":"Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage.","volume":"314","author":"Roviezzo","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI58832","article-title":"Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.","volume":"122","author":"Felcht","year":"2012","journal-title":"J Clin Invest"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"e70459","DOI":"10.1371\/journal.pone.0070459","article-title":"Angiopoietin-2 is critical for cytokine-induced vascular leakage.","volume":"8","author":"Benest","year":"2013","journal-title":"PLoS One"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1172\/JCI66549","article-title":"Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis.","volume":"123","author":"Ziegler","year":"2013","journal-title":"J Clin Invest"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1097\/CCM.0b013e31825fdc31","article-title":"Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis*.","volume":"40","author":"David","year":"2012","journal-title":"Crit Care Med"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12726","article-title":"Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation.","volume":"1347","author":"Scholz","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/CCM.0b013e318206d285","article-title":"Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis.","volume":"39","author":"Ricciuto","year":"2011","journal-title":"Crit Care Med"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","article-title":"Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans.","volume":"3","author":"Parikh","year":"2006","journal-title":"PLoS Med"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.201208-1460OC","article-title":"Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.","volume":"187","author":"Agrawal","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/CCM.0b013e3182451c87","article-title":"Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance.","volume":"40","author":"Calfee","year":"2012","journal-title":"Crit Care Med"},{"key":"R14-20230728","first-page":"1121","article-title":"Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis.","volume":"68","author":"Fremont","year":"2010","journal-title":"J Trauma"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"e108862","DOI":"10.1371\/journal.pone.0108862","article-title":"Association of angiopoietin-2 with renal outcome in chronic kidney disease.","volume":"9","author":"Tsai","year":"2014","journal-title":"PLoS One"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00134-009-1726-7","article-title":"Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome.","volume":"36","author":"K\u00fcmpers","year":"2010","journal-title":"Intensive Care Med"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.2009.159","article-title":"Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury.","volume":"76","author":"Bouchard","year":"2009","journal-title":"Kidney Int"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10753-012-9534-6","article-title":"The dynamics of angiogenic factors and their soluble receptors in relation to organ dysfunction in disseminated intravascular coagulation associated with sepsis.","volume":"36","author":"Jesmin","year":"2013","journal-title":"Inflammation"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00134-009-1560-y","article-title":"Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality.","volume":"35","author":"van der Heijden","year":"2009","journal-title":"Intensive Care Med"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"e1360","DOI":"10.1097\/MD.0000000000001360","article-title":"Postoperative fluid overload is a useful predictor of the short-term outcome of renal replacement therapy for acute kidney injury after cardiac surgery.","volume":"94","author":"Xu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/cc6966","article-title":"Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays.","volume":"12","author":"Lukasz","year":"2008","journal-title":"Crit Care"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201302-0355OC","article-title":"Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.","volume":"188","author":"Russell","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"e79207","DOI":"10.1371\/journal.pone.0079207","article-title":"Cytokines and signaling molecules predict clinical outcomes in sepsis.","volume":"8","author":"Fjell","year":"2013","journal-title":"PLoS One"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/cc6966","article-title":"Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays.","volume":"12","author":"Lukasz","year":"2008","journal-title":"Crit Care"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock.","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","article-title":"Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality.","volume":"39","author":"Boyd","year":"2011","journal-title":"Crit Care Med"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study.","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/2110-5820-2-S1-S1","article-title":"Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance.","volume":"2","author":"Cordemans","year":"2012","journal-title":"Ann Intensive Care"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1186\/cc10523","article-title":"The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis.","volume":"15","author":"Kumpers","year":"2011","journal-title":"Crit Care"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cyto.2011.04.005","article-title":"Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis.","volume":"55","author":"David","year":"2011","journal-title":"Cytokine"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00134-009-1560-y","article-title":"Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality.","volume":"35","author":"van der Heijden","year":"2009","journal-title":"Intensive Care Med"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMcibr1007320","article-title":"Sepsis and endothelial permeability.","volume":"363","author":"Lee","year":"2010","journal-title":"N Engl J Med"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2014.03.016","article-title":"Damage of the endothelial glycocalyx in chronic kidney disease.","volume":"234","author":"Padberg","year":"2014","journal-title":"Atherosclerosis"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00134-002-1615-9","article-title":"Fluid responsiveness in mechanically ventilated patients: a review of indices used in intensive care.","volume":"29","author":"Bendjelid","year":"2003","journal-title":"Intensive Care Med"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/CCM.0b013e31828a25fd","article-title":"Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense.","volume":"41","author":"Marik","year":"2013","journal-title":"Crit Care Med"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies.","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"L955","DOI":"10.1152\/ajplung.00449.2007","article-title":"Regulation of angiopoietin expression by bacterial lipopolysaccharide.","volume":"294","author":"Mofarrahi","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R39-20230728","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V90.4.1558","article-title":"Fluid shear stress modulates von Willebrand factor release from human vascular endothelium.","volume":"90","author":"Galbusera","year":"1997","journal-title":"Blood"},{"key":"R40-20230728","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1681\/ASN.2013050542","article-title":"Angiopoietin-2-induced arterial stiffness in CKD.","volume":"25","author":"Chang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R41-20230728","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.CCM.0000251640.77679.D7","article-title":"Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.","volume":"35","author":"Orfanos","year":"2007","journal-title":"Crit Care Med"},{"key":"R42-20230728","doi-asserted-by":"crossref","first-page":"H215","DOI":"10.1152\/ajpheart.00895.2011","article-title":"Angiopoietin-2 promotes inflammatory lymphangiogenesis and its effect can be blocked by the specific inhibitor L1-10.","volume":"302","author":"Yan","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R43-20230728","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1164\/rccm.201311-2097OC","article-title":"Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill.","volume":"189","author":"Linder","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-20230728","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJMra032401","article-title":"Acute renal failure and sepsis.","volume":"351","author":"Schrier","year":"2004","journal-title":"N Engl J Med"},{"key":"R45-20230728","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"key":"R46-20230728","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1748-1716.1990.tb08808.x","article-title":"Mechanism of erythrocyte trapping in ischaemic acute renal failure.","volume":"138","author":"Bayati","year":"1990","journal-title":"Acta Physiol Scand"},{"key":"R47-20230728","doi-asserted-by":"crossref","first-page":"R278","DOI":"10.1186\/cc13133","article-title":"Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study.","volume":"17","author":"Legrand","year":"2013","journal-title":"Crit Care"},{"key":"R48-20230728","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/cc6916","article-title":"A positive fluid balance is associated with a worse outcome in patients with acute renal failure.","volume":"12","author":"Payen","year":"2008","journal-title":"Crit Care"},{"key":"R49-20230728","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/CCM.0b013e318246b9c6","article-title":"An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial.","volume":"40","author":"Bellomo","year":"2012","journal-title":"Crit Care Med"},{"key":"R50-20230728","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ndt\/gfs336","article-title":"Pleiotropic effects of angiopoietin-2 deficiency do not protect mice against endotoxin-induced acute kidney injury.","volume":"28","author":"Kurniati","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R51-20230728","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1164\/rccm.201311-2097OC","article-title":"Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill.","volume":"189","author":"Linder","year":"2014","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201611000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T08:39:18Z","timestamp":1690533558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201611000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000001853","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}